The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Hydrogen peroxide secreted by tumor‐derived macrophages down‐modulates signal‐transducing zeta molecules and inhibits tumor‐specific T cell‐and natural killer cell‐mediated cytotoxicity
Abstract
Although alterations in CD3‐associated signal‐transducing molecules in tumor‐infiltrating T cells of patients with advanced cancer have been previously described, the mechanism behind these changes is not known. We demonstrate that macrophages isolated from metastatic lymph nodes of patients with malignant melanoma down‐regulate levels of CD3ζ in autologous peripheral blood T cells. Lipopolysaccharide (LPS)‐ or phorbol 12‐myristate 13‐acetate (PMA)‐stimulated monocytes derived from peripheral blood of healthy donors also induced decreased expression of CD3 and CD16‐associated ζ chains similar to that observed in T cells and natural killer (NK) cells of patients with advanced cancer. Co‐culture with activated monocytes impaired Ca 2+ mobilization in peripheral blood derived‐T cells when stimulated with monoclonal antibodies to CD3 and also strongly inhibited melanoma‐specific cytotoxic T lymphocyte (CTL) activity and NK activity. The presence of catalase, a scavenger of H 2 O 2, during co‐culture almost totally abrogated the inhibitory effect of activated monocytes on melanoma‐specific CTL lines and on NK cells. Pre‐treatment of CTL or NK cells with nontoxic concentrations (1 × 10−5 M) of H 2 O 2 also severely reduced their cytotoxic activity which could be prevented by catalase. The decrease in CD3ζ and in CD16ζ expression, induced by macrophages isolated from metastatic lymph nodes or by LPS‐stimulated monocytes, was also prevented by catalase when maintained throughout the co‐culture period. The possibility that monocyte/macrophage‐derived reactive oxygen metabolites contribute directly to alterations in signal transducing molecules of T cells and NK cells and to the mechanism of immunosuppression in individuals with cancer should be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The origin and function of tumor-associated macrophages
Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., & Ruco, L. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90008-u · Cited by 1,089
Alterations in Signal Transduction Molecules in T Lymphocytes from Tumor-Bearing Mice
Mizoguchi, H., O'Shea, J. J., Longo, D. L., Loeffler, C. M., McVicar, D. W., & Ochoa, A. C. (1992) · Science · doi:10.1126/science.1465616 · Cited by 632
Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis.
Miyake, K., Weissman, I. L., Greenberger, J. S., & Kincade, P. W. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.599 · Cited by 589
Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma.
Finke, J. H., Zea, A. H., Stanley, J., Longo, D., Mizoguchi, H., Tubbs, R. R., Wiltrout, R. H., O’Shea, J. J., Kudoh, S., & Klein, E. A. (1993) · PubMed · Cited by 379
SUSSMAN, J. (1988) · Cell · doi:10.1016/0092-8674(88)90533-8 · Cited by 348
Nakagomi, H., Petersson, M., Magnusson, I., Juhlin, C., Matsuda, M., Mellstedt, H., Taupin, J., Vivier, É., Anderson, P., & Kiessling, R. W. (1993) · PubMed · Cited by 339
Self-citationSecrist, J. P., Burns, L. A., Karnitz, L., Koretzky, G. A., & Abraham, R. T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53403-7 · Cited by 317
Miescher, S., Whiteside, T. L., Carrel, S., & von Fliedner, V (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.5.1899 · Cited by 312
Matsuda, M., Salazar, F., Petersson, M., Masucci, G., Hansson, J., Pisa, P., Zhang, Q. J., Masucci, M. G., & Kiessling, R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2371 · Cited by 306
Self-citationTimonen, T., Saksela, E., Ranki, A., & Häyry, P. (1979) · Cellular Immunology · doi:10.1016/0008-8749(79)90106-0 · Cited by 265
Low levels of reactive oxygen species as modulators of cell function
Remacle, J., Raes, M., Toussaint, O., Renard, P., & Rao, G. (1995) · Mutation Research/DNAging · doi:10.1016/0921-8734(95)90004-7 · Cited by 255
Matsuda, M., Petersson, M., Lenkei, R., Taupin, J., Magnusson, I., Mellstedt, H., Anderson, P., & Kiessling, R. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610605 · Cited by 208
Self-citationRedox regulation of a src family protein tyrosine kinase p56lck in T cells.
Nakamura, K., Hori, T., Sato, N., Sugie, K., Kawakami, T., & Yodoi, J. (1993) · PubMed · Cited by 199
Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites.
Hellstrand, K., Asea, A., Dahlgren, C., & Hermodsson, S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.11.4940 · Cited by 185
Vandenberghe, P. A., & Ceuppens, J. L. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90069-8 · Cited by 176
Anderson, P., Caligiuri, M., O'Brien, C., Manley, T., Ritz, J., & Schlossman, S. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2274 · Cited by 171
Self-citationMartin, J. H., & Edwards, S. W. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.8.3478 · Cited by 170
Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex.
Aoe, T., Okamoto, Y., & Saito, T. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.5.1881 · Cited by 145
Vivier, É., Morin, P. M., O’Brien, C., Druker, B. J., Schlossman, S. F., & Anderson, P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.1.206 · Cited by 139
Self-citationSeaman, W. E., Gindhart, T. D., Blackman, M. A., Dalal, B. I., Talal, N., & Werb, Z. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110527 · Cited by 126
Vivier, É., da Silva, A. J., Ackerly, M., Levine, H., Rudd, C. E., & Anderson, P. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230821 · Cited by 81
Self-citationRapid turnover of the CD3ζ chain independent of the TCR-CD3 complex in normal T cells
Ono, S., Ohno, H., & Salto, T. (1995) · Immunity · doi:10.1016/1074-7613(95)90008-x · Cited by 77
Gunji, Y., Hori, S., Aoe, T., Asano, T., Ochiai, T., Isono, K., & Saito, T. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02927.x · Cited by 51
Bottino, C., Vitale, M., Olcese, L., Sivori, S., Morelli, L., Augugliaro, R., Ciccone, E., Moretta, L., & Moretta, A. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241040 · Cited by 51
Effect of catalase on the proliferation of human lymphocytes to phorbol myristate acetate.
Sagone, A. L., Husney, R. M., Guter, H., & Clark, L. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.3.1488 · Cited by 29
Cited by
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
The role of ROS in tumour development and progression
Cheung, E. C., & Vousden, K. H. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00435-0 · Cited by 1,595
Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0465 · Cited by 1,276
Rodríguez, P. C., & Ochoa, A. C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00608.x · Cited by 719
Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism
Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., Zanovello, P., & Segal, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.689 · Cited by 690
Metadata
- Authors
- Kono, K., Salazar‐Onfray, F., Petersson, M., Hansson, J., Masucci, G., Wasserman, K., Nakazawa, T., Anderson, P., & Kiessling, R.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1996-06
- Volume
- 26
- Issue
- 6
- Pages
- 1308-1313
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2075735730
- Cited by
- 359
- References
- 25
- FWCI
- 6.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.